指南与共识真菌感染

罕见霉菌感染诊断与管理全球指南:ECMM、ISHAM与ASM联合倡议

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.
指南 / 共识 · Lancet Infect Dis · 2021-02-16

随着重症及免疫抑制患者增多,非曲霉、非毛霉的罕见霉菌感染增加,抗真菌预防选择性压力导致突破性感染增多。来自24个国家的专家分析已发表证据,制定罕见霉菌感染诊断与治疗的共识指南,旨在为临床决策提供实用指导并识别管理中的不确定性。

要点

  • 罕见霉菌感染在免疫抑制及重症患者中增多,抗真菌预防可致突破性感染。
  • 管理路径取决于诊断与治疗手段的可及性,需多学科协作。
  • 指南由24国专家基于已发表证据制定,属One World-One Guideline倡议。

核心结论

  • 罕见霉菌感染管理复杂,需多学科协作,本共识提供实用临床决策指导。

研究设计与样本

  • 来自24个国家的专家分析已发表证据,制定罕见霉菌感染诊断与治疗共识指南。

主要发现

  • 抗真菌预防有效预防多种侵袭性真菌感染,但选择性压力导致由Fusarium、Lomentospora、Scedosporium及暗色霉菌等引起的突破性感染增加。

临床怎么用

  • 管理路径应依据当地诊断与治疗选项的可及性,并纳入区域流行病学差异。

局限性

  • 本文识别了罕见霉菌感染优化管理中的不确定领域与限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World-One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hoenigl M, Salmanton-García J, Walsh TJ, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis. 2021. PMID: 33606997. doi:10.1016/S1473-3099(20)30784-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。